Abstract:The merging of three-dimensional in vitro models with multi-organ-on-a-chip (MOC) technology has taken in vitro assessment of chemicals to an unprecedented level. By connecting multiple organotypic models, MOC allows for the crosstalk between different organs to be studied to evaluate a compound's safety and efficacy better than with single cultures. The technology could also improve the toxicological assessment of aerosols that have been implicated in the development of chronic obstructive pulmonary disease, asthma, or lung cancer. Here we report the development of a lung/liver-on-a-chip, connecting in a single circuit, normal human bronchial epithelial (NHBE) cells cultured at the air-liquid interface (ALI), and HepaRG™ liver spheroids. Maintenance of the individual tissues in the chip increased NHBE ALI tissue transepithelial electrical resistance and decreased HepaRG™ spheroid adenosine triphosphate content as well as cytochrome P450 (CYP) 1A1/1B1 inducibility. CYP inducibility was partly restored when HepaRG™ spheroids were cocultured with NHBE ALI tissues. Both tissues remained viable and functional for 28 days when cocultured in the chip. The capacity of the HepaRG™ spheroids to metabolize compounds present in the medium and to modulate their toxicity was proven using aflatoxin B1 (AFB1). AFB1 toxicity in NHBE ALI tissues decreased when HepaRG™ spheroids were present in the same chip circuit, proving that the HepaRG™-mediated detoxification is protecting/decreasing from AFB1-mediated cytotoxicity. The lung/liver-on-a-chip platform presented here offers new opportunities to study the toxicity of inhaled aerosols or to demonstrate the safety and efficacy of new drug candidates targeting the human lung.

Recapitulating essential pathophysiological characteristics in lung-on-a-chip for disease studies

Recent advances in lung-on-a-chip technology for modeling respiratory disease

Physiological and Disease Models of Respiratory System Based on Organ-on-a-Chip Technology

Short-term ex vivo tissue culture models help study human lung infectionsA review

Progress and application of lung-on-a-chip for lung cancer

Airway-On-A-Chip: Designs and Applications for Lung Repair and Disease

A Microfluidic Lung-on-a-chip Based on Biomimetic Hydrogel Membrane

Microfluidic-Chip-Integrated Biosensors for Lung Disease Models.

Advancements in Preclinical Human-Relevant Modeling of Pulmonary Vasculature On-Chip

Use of three-dimensional organoids and lung-on-a-chip methods to study lung development, regeneration and disease

Microfluidic Strategies for Biomimetic Lung Chip Establishment and SARS-CoV2 Study

Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review

Reconstituting organ-level lung functions on a chip

What can an organ-on-a-chip teach us about human lung physiology?

A storm in a teacup -- A biomimetic lung microphysiological system in conjunction with a deep-learning algorithm to monitor lung pathological and inflammatory reactions

Integration of bioprinting advances and biomechanical strategies for in vitro lung modelling

Advanced lung organoids for respiratory system and pulmonary disease modeling

Lung-on-a-Chip Systems and Other 3D Cultures

A lung/liver-on-a-chip platform for acute and chronic toxicity studies

Modeling Pulmonary Cystic Fibrosis in a Human Lung Airway-on-a-chip